CJC Pediatric and Congenital Heart Disease最新文献_第6页

Rethinking Paediatric Cardiology Training in Canada 加拿大儿科心脏病学培训的反思

CJC Pediatric and Congenital Heart Disease Pub Date : 2024-02-01 DOI: 10.1016/j.cjcpc.2023.11.002

Michael N. Gritti MD , Conall T. Morgan MD

引用次数: 0

The Deleterious Consequences of a Nonsteroidal Anti-inflammatory Drug in an Eisenmenger Patient 艾森曼格患者服用非甾体抗炎药的不良后果

CJC Pediatric and Congenital Heart Disease Pub Date : 2024-02-01 DOI: 10.1016/j.cjcpc.2023.10.011

Sarah Grütter , David Haefliger MD , Grégoire Wuerzner MD, PhD , Patrick Yerly MD , Judith Bouchardy MD , Tobias Rutz MD

引用次数: 0

Advances in Fetal Cardiac Imaging and Intervention 胎儿心脏成像和干预的进展

CJC Pediatric and Congenital Heart Disease Pub Date : 2024-02-01 DOI: 10.1016/j.cjcpc.2023.10.012

Nathaniel Barber MBBS, MSc, Lindsay Freud MD

引用次数: 0

Information for Readers 读者信息

CJC Pediatric and Congenital Heart Disease Pub Date : 2024-02-01 DOI: 10.1016/S2772-8129(24)00004-6

引用次数: 0

QTc Interval Prolongation and Its Association With Electrolyte Abnormalities and Psychotropic Drug Use Among Patients With Eating Disorders 饮食失调患者的 QTc 间期延长及其与电解质异常和精神药物使用的关系

CJC Pediatric and Congenital Heart Disease Pub Date : 2024-02-01 DOI: 10.1016/j.cjcpc.2023.09.010

Myles Benayon BSc, MD , Lekhini Latchupatula BHSc, MD , Emily Kacer BSc , Maaz Shanjer MD , Ethan Weiss BSc, MD , Shawnee Amar BMSc Candidate , Noah Zweig BSc Candidate , Mehran Ghadim BSc , Robert Portman BSc , Narayanaswamy Balakrishnan BSc, MSc, PhD , Hon Yiu So BSc, MPhil, PhD , Sheri Findlay MD, FRCPC , Natasha Johnson MD, FRCPC, FAAP , Tapas Mondal MD, MRCPCH, FRCPC

{"title":"QTc Interval Prolongation and Its Association With Electrolyte Abnormalities and Psychotropic Drug Use Among Patients With Eating Disorders","authors":"Myles Benayon BSc, MD , Lekhini Latchupatula BHSc, MD , Emily Kacer BSc , Maaz Shanjer MD , Ethan Weiss BSc, MD , Shawnee Amar BMSc Candidate , Noah Zweig BSc Candidate , Mehran Ghadim BSc , Robert Portman BSc , Narayanaswamy Balakrishnan BSc, MSc, PhD , Hon Yiu So BSc, MPhil, PhD , Sheri Findlay MD, FRCPC , Natasha Johnson MD, FRCPC, FAAP , Tapas Mondal MD, MRCPCH, FRCPC","doi":"10.1016/j.cjcpc.2023.09.010","DOIUrl":"10.1016/j.cjcpc.2023.09.010","url":null,"abstract":"<div><h3>Background</h3><p>Eating disorders (EDs) often develop during adolescence with high mortality rates. Sudden cardiac death in these patients has been associated with corrected QT (QTc) interval prolongation. The significance of extrinsic factors on QTc prolongation in populations with EDs remains controversial. This study assessed the relationship between QTc prolongation in paediatric patients with EDs and extrinsic factors, such as QTc-prolonging medications and electrolyte abnormalities to investigate whether an ED alone is associated with an increased prevalence of QTc prolongation.</p></div><div><h3>Methods</h3><p>Electrocardiograms, electrolytes, and psychopharmaceutical usage were retrospectively analysed from the charts of 264 paediatric patients with EDs. Descriptive statistics were used to assess QTc prolongation and its relationship with electrolyte abnormalities and psychopharmaceuticals.</p></div><div><h3>Results</h3><p>Of 264 patients, 227 had normal QTc intervals (<440 ms), whereas 37 had borderline prolonged (440-460 ms) or prolonged (>460 ms) intervals. The prevalence of QTc intervals exceeding 440 ms in patients with normal electrolytes and not using QTc-prolonging psychotropics mirrored that of the general population (<em>P</em> = 0.59). Of the 23 patients taking psychotropics, 8 had abnormal QTc intervals. The average QTc was greater for patients using QTc-prolonging psychotropics (<em>P</em> = 0.05) with a correlation between interval length and psychotropic usage (<em>P</em> < 0.01). Average potassium (<em>P</em> = 0.08), calcium (<em>P</em> = 0.18), and magnesium (<em>P</em> = 0.08) levels did not significantly differ between those with normal and abnormal QTc intervals.</p></div><div><h3>Conclusions</h3><p>This study suggests that EDs alone may not prolong QTc intervals in paediatric patients with EDs, but psychotropics appear to be a salient external factor in QTc prolongation.</p></div>","PeriodicalId":100249,"journal":{"name":"CJC Pediatric and Congenital Heart Disease","volume":"3 1","pages":"Pages 14-21"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772812923001367/pdfft?md5=c94ad84c5227cc196c23295e9686bdc1&pid=1-s2.0-S2772812923001367-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138625386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

“We have dealt with so much. There’s more coming?”: Improving Knowledge About Brain Health in Adults Living With Congenital Heart Disease "我们已经处理了这么多事情。还会有更多？增进先天性心脏病患者的脑健康知识

CJC Pediatric and Congenital Heart Disease Pub Date : 2024-02-01 DOI: 10.1016/j.cjcpc.2023.10.010

Ismalia De Sousa PhD(c), MSc, RN , Vanessa Dizonno MSc , Karen LeComte MSN, RN , Alexis Carr MBBS, MSci, MHSc , Yussef El Kalza HBA , Mikayla Shymka BSc , Roger H. Payette BSc , Leah Kuzmuk MSc , Emily M.E. Lyall MD, CCFP , Jasmine Grewal MD , Jonathan M.C. Smith MD, MHSc , Thalia S. Field MD, FRCPC, MHSc

{"title":"“We have dealt with so much. There’s more coming?”: Improving Knowledge About Brain Health in Adults Living With Congenital Heart Disease","authors":"Ismalia De Sousa PhD(c), MSc, RN , Vanessa Dizonno MSc , Karen LeComte MSN, RN , Alexis Carr MBBS, MSci, MHSc , Yussef El Kalza HBA , Mikayla Shymka BSc , Roger H. Payette BSc , Leah Kuzmuk MSc , Emily M.E. Lyall MD, CCFP , Jasmine Grewal MD , Jonathan M.C. Smith MD, MHSc , Thalia S. Field MD, FRCPC, MHSc","doi":"10.1016/j.cjcpc.2023.10.010","DOIUrl":"10.1016/j.cjcpc.2023.10.010","url":null,"abstract":"<div><h3>Background</h3><p>Significant advances in managing congenital heart disease (CHD) have occurred over the past few decades, resulting in a fast-growing adult patient population with distinct needs requiring urgent attention. Research has recently highlighted the prevalence of neurocognitive differences among adults living with CHD. Yet, there is a lack of knowledge about the perspectives of people living with CHD and family members/caregivers on brain health. We sought to explore their perspectives to guide future research and clinical endeavours.</p></div><div><h3>Methods</h3><p>Using the principles of integrated knowledge translation and qualitative interpretive description, we conducted 2 focus groups with 7 individuals with CHD and their family members as part of a virtual forum on brain health in CHD. Data analysis followed the principles of interpretive description.</p></div><div><h3>Results</h3><p>A lack of understanding about overall brain health and neurocognitive differences in adult CHD was identified. To increase overall knowledge about brain health, initiatives should (1) focus on the individual living with CHD, involving family members and peers; (2) use social media and health care encounters for knowledge exchange; and (3) ensure a “balancing act” in the information provided to avoid feelings of worry and uncertainty about the future while simultaneously empowering people living with CHD.</p></div><div><h3>Conclusions</h3><p>There is a pressing need for better education about brain health among individuals living with CHD. Our findings can guide clinicians in developing programmes of care and (re)design health services that address the brain-heart axis and neurocognitive differences in CHD.</p></div>","PeriodicalId":100249,"journal":{"name":"CJC Pediatric and Congenital Heart Disease","volume":"3 1","pages":"Pages 1-10"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772812923001616/pdfft?md5=08471eabbea01c56b163fbc0b226843b&pid=1-s2.0-S2772812923001616-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136128237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Congenital Tracheal Stenosis Patients Undergoing Modified Slide Tracheoplasty: Single-Centre Technique and Long-Term Morbidity and Mortality 接受改良滑动气管成形术的先天性气管狭窄患者：单中心技术与长期发病率和死亡率

CJC Pediatric and Congenital Heart Disease Pub Date : 2024-02-01 DOI: 10.1016/j.cjcpc.2023.10.003

Ryaan EL-Andari MD , Rami Zibdawi BSc, MSc , Paula Holinski MD , John Koller MD , Chloe Joynt MD , Nee Khoo MBChB , Laurance Lequier MD , Hamdy El-Hakim MD , Mohammed Al Aklabi FRCSC, MD

{"title":"Congenital Tracheal Stenosis Patients Undergoing Modified Slide Tracheoplasty: Single-Centre Technique and Long-Term Morbidity and Mortality","authors":"Ryaan EL-Andari MD , Rami Zibdawi BSc, MSc , Paula Holinski MD , John Koller MD , Chloe Joynt MD , Nee Khoo MBChB , Laurance Lequier MD , Hamdy El-Hakim MD , Mohammed Al Aklabi FRCSC, MD","doi":"10.1016/j.cjcpc.2023.10.003","DOIUrl":"10.1016/j.cjcpc.2023.10.003","url":null,"abstract":"<div><h3>Background</h3><p>Congenital malformations of the trachea are rare but often life-threatening. Limited data have been published on the outcomes of tracheal reconstruction for congenital tracheal stenosis. We sought to describe the outcomes of patients undergoing tracheal reconstruction over 10 years at our centre.</p></div><div><h3>Methods</h3><p>All paediatric patients who underwent long-segment tracheal or bronchial reconstruction from January 1, 2012, to August 31, 2022, were included. The primary outcome was mortality, and secondary outcomes included reoperation and postoperative morbidity. Patients were followed up to 10 years.</p></div><div><h3>Results</h3><p>Thirty-three patients with ages ranging from 1 day to 12 years (mean 8.5 months) at the time of tracheoplasty or bronchoplasty were included, with 5 patients undergoing off-pump tracheal reconstruction. The most common preoperative comorbidities included patent ductus arteriosus (30.3%), atrial septal defect (27.3%), and prematurity (24.2%). There were no deaths postoperatively within the follow-up period. All patients experienced successful reconstruction with no patients requiring reoperation of the trachea. A total of 14 patients (42.4%) required postoperative balloon dilation, 3 (9.1%) required bronchial repair after tracheal repair, and 2 (6.1%) required bronchoscopic tracheal debridement.</p></div><div><h3>Conclusions</h3><p>This single-centre retrospective study provides a large cohort of congenital tracheal reconstruction patients with a survival rate of 100%, experiencing no mortality during follow-up. The majority of patients had preoperative comorbidities and concomitant congenital cardiac defects. Although tracheal reconstruction continues to be complex with significant postoperative morbidity and mortality, the results of our single-centre study demonstrate the continual advancement of this field and the evolving improvement of postoperative outcomes for these patients.</p></div>","PeriodicalId":100249,"journal":{"name":"CJC Pediatric and Congenital Heart Disease","volume":"3 1","pages":"Pages 24-32"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772812923001549/pdfft?md5=372002f31b6b9ab6d7e4a17cde9d24d0&pid=1-s2.0-S2772812923001549-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135760555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Role of Congenital Heart Disease Patient Organizations in Advocacy, Resources, and Support Across the Lifespan 先天性心脏病患者组织在倡导、资源和生命周期支持中的作用

CJC Pediatric and Congenital Heart Disease Pub Date : 2023-12-01 DOI: 10.1016/j.cjcpc.2023.08.006

Shelagh Ross BA , Amy Verstappen MGH

{"title":"The Role of Congenital Heart Disease Patient Organizations in Advocacy, Resources, and Support Across the Lifespan","authors":"Shelagh Ross BA , Amy Verstappen MGH","doi":"10.1016/j.cjcpc.2023.08.006","DOIUrl":"10.1016/j.cjcpc.2023.08.006","url":null,"abstract":"<div><p>Congenital heart disease patient organizations, comprising experts with lived experience, and their families and supporters, have become an essential voice for patient advocacy, resources, and support. Thanks largely to the Internet, these organizations are growing in number worldwide. Their common voice can be used to influence research, be the catalyst for advocacy efforts for new programmes and supports, and connect patients and providers in endeavours beyond the clinical setting. The result has become more active engagement with how policy decisions, research directions, and laws are decided that will shape patients’ lives. From advocating for much-needed mental health support, policies to combat discrimination and the lack of access to support services, and partnerships with clinicians and others to develop educational resources and tools, congenital heart disease patient organizations are having a considerable impact on patient lives and ultimately patient outcomes.</p></div>","PeriodicalId":100249,"journal":{"name":"CJC Pediatric and Congenital Heart Disease","volume":"2 6","pages":"Pages 256-266"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772812923001288/pdfft?md5=4195ba08c3dc996442026be648b6ff68&pid=1-s2.0-S2772812923001288-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135889259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Cannabis Use: A New Risk Behaviour Among Adults With Congenital Heart Disease 使用大麻：先天性心脏病成人中的一种新风险行为

CJC Pediatric and Congenital Heart Disease Pub Date : 2023-12-01 DOI: 10.1016/j.cjcpc.2023.09.001

Barbara Bailey MN , Michelle A. Dimas MSc , Erwin Oechslin MD , Shereli Soldevilla MN , Rima Styra MD

{"title":"Cannabis Use: A New Risk Behaviour Among Adults With Congenital Heart Disease","authors":"Barbara Bailey MN , Michelle A. Dimas MSc , Erwin Oechslin MD , Shereli Soldevilla MN , Rima Styra MD","doi":"10.1016/j.cjcpc.2023.09.001","DOIUrl":"10.1016/j.cjcpc.2023.09.001","url":null,"abstract":"<div><h3>Background</h3><p>Cannabis use has increased in Canada and can be associated with adverse cardiovascular events. Given increased use and accessibility to cannabis, there is a need among clinicians to better understand cannabis use in adults with congenital heart disease.</p></div><div><h3>Methods</h3><p>A cross-sectional survey (May to September 2018) was used to investigate cannabis use among 252 patients with adult congenital heart disease in a quaternary care centre.</p></div><div><h3>Results</h3><p>Of the 252 patients, 53 (21%) reported using cannabis. The majority of cannabis users were men (62%), between the ages of 25 and 39 years (mean age = 32 ± 16 years), and more likely to use tobacco (n = 9, 17%; <em>P</em> = 0.001) and alcohol (n = 37, 60%; <em>P</em> = 0.001). Significant differences (<em>P</em> = 0.011) were found between the age of onset for tobacco use among cannabis users (mean age: 16 ± 8 years) and non-cannabis users (mean age: 20 ± 3 years). Users reported consuming cannabis for recreational purposes (n = 29, 55%), anxiety (n = 22, 42%), depression (n = 15, 28%), and pain management (n = 4, 8%).</p></div><div><h3>Conclusions</h3><p>This study supports our clinical experience that a high proportion of patients with adult congenital heart disease use cannabis. Cannabis users represent a patient population who may demonstrate less optimal health behaviours, including tobacco and alcohol use. Assessment of cannabis use should be an integral part of risk behaviour and cardiovascular risk profile at each clinic visit. Given the current legalization of cannabis in Canada and the growing increase of cannabis use, educational support should be provided to patients and caregivers.</p></div>","PeriodicalId":100249,"journal":{"name":"CJC Pediatric and Congenital Heart Disease","volume":"2 6","pages":"Pages 484-489"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772812923001252/pdfft?md5=dff17d0552368a07ad41828b619d6844&pid=1-s2.0-S2772812923001252-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83349951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Use of 3-Dimensional Echocardiography for Tricuspid Valve Surgery in Hypoplastic Left Heart Syndrome 三维超声心动图在左心发育不全综合征三尖瓣手术中的应用

CJC Pediatric and Congenital Heart Disease Pub Date : 2023-12-01 DOI: 10.1016/j.cjcpc.2023.10.005

Andrea Pisesky MD , Osami Honjo MD, PhD , Olivier Villemain MD, PhD , Andreea Dragulescu MD, PhD

引用次数: 0